secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALX ONCOLOGY HOLDINGS INC (ALXO)
CIK:        0001810182
Form:       8-K
Filed at:   2023-10-04T23:59:59+00:00
Accession:  0001193125-23-250822
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

ALX Oncology reports preliminary Q3 2023 cash position of $196.5M
-----------------------------------------------------------------

- Preliminary cash, cash equivalents, and investments of $196.5M as of Sep 30, 2023, subject to quarter-end close.
- Estimate is unaudited and may change upon completion of financial statement closing procedures.
- No other Q3 financial results released; full report expected later.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810182/000119312523250822/0001193125-23-250822-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810182/000119312523250822/d537542d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-250822

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer